Patricia Phillips

Patricia Phillips is a seasoned professional in market analytics and research with extensive experience in the pharmaceutical and biopharmaceutical industries. Currently serving as the Director of Market Analytics at NOVAVAX INC since January 2022, Patricia plays a crucial role in shaping the narrative around the COVID-19 pandemic through a novel vaccine. Previously, Patricia held significant roles at Daiichi Sankyo, Inc. from January 2007 to October 2021, including Associate Director of Global Market Research & Analytics for Oncology Brands, where responsibilities encompassed primary and secondary market research for oncology compounds. Earlier career positions include Market Research Manager at Novo Nordisk and Client Services Manager at Skila Inc, where Patricia supported the launch of numerous drugs globally. Patricia's foundational experience in R&D was established at Church & Dwight and Colgate-Palmolive. Educational achievements include an MBA in Marketing and a B.A. in Biology from Rutgers University.